ClinVar Miner

Submissions for variant NM_001130987.2(DYSF):c.5976A>C (p.Pro1992=)

gnomAD frequency: 0.23571  dbSNP: rs17718530
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 17
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000080315 SCV000112210 benign not specified 2013-09-19 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000080315 SCV000269058 benign not specified 2015-01-13 criteria provided, single submitter clinical testing p.Pro1992Pro in exon 53 of DYSF: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 25.0% (2153/8600) of European American chromosomes from a broad population by the NHLBI Exome Seq uencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs17718530).
PreventionGenetics, part of Exact Sciences RCV000080315 SCV000309701 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000282030 SCV000431848 likely benign Limb-girdle muscular dystrophy, recessive 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000316074 SCV000431849 likely benign Miyoshi myopathy 2016-06-14 criteria provided, single submitter clinical testing
GeneDx RCV000080315 SCV000519374 benign not specified 2016-01-05 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Athena Diagnostics RCV000080315 SCV000677281 benign not specified 2021-05-24 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001142849 SCV001303337 benign Qualitative or quantitative defects of dysferlin 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV001142849 SCV001722440 benign Qualitative or quantitative defects of dysferlin 2025-02-03 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001527272 SCV001738230 benign Miyoshi muscular dystrophy 1 2021-06-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001274111 SCV001875874 benign Autosomal recessive limb-girdle muscular dystrophy type 2B 2021-07-30 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001664348 SCV001875875 benign Distal myopathy with anterior tibial onset 2021-07-30 criteria provided, single submitter clinical testing
Breakthrough Genomics, Breakthrough Genomics RCV004710478 SCV005257529 likely benign not provided criteria provided, single submitter not provided
Genetic Services Laboratory, University of Chicago RCV000080315 SCV000151037 likely benign not specified no assertion criteria provided clinical testing Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.
Natera, Inc. RCV001274111 SCV001457857 benign Autosomal recessive limb-girdle muscular dystrophy type 2B 2020-09-16 no assertion criteria provided clinical testing
Clinical Genetics, Academic Medical Center RCV000080315 SCV001918886 benign not specified no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000080315 SCV001954812 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.